Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-10

Clinical Trial Update: Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the long-term effects of intravitreal anti-VEGF therapy for branch retinal vein occlusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravitreal anti-VEGF

Snippet

Sponsor: Medical University of Vienna | Conditions: Branch Retinal Vein Occlusion | Phase 3 | Status: COMPLETED